Article Text

Download PDFPDF
Letter
Decreasing incidence of retinopathy of prematurity requiring treatment
  1. Gemma Ginovart1,
  2. Sergio Verd2
  1. 1 Department of Paediatrics, Neonatal Unit, Hospital de la Santa Creu i Sant Pau, Barcelona Free University (UAB), Barcelona, Spain
  2. 2 Department of Primary Care, Balearic Health Authority, Pediatric Unit, La Vileta Surgery, Health Sciences Research Institute (IUNICS), Palma de Mallorca, Balearic Islands, Spain
  1. Correspondence to Dr Sergio Verd, Balearic Health Authority, Department of Primary Care, Pediatric Unit, La Vileta Surgery, Health Sciences Research Institute (IUNICS), Palma de Mallorca 07013, Spain; drsverd{at}gmail.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Clinical interventions to reduce the development of retinopathy of prematurity (ROP) have been limited because postnatal risk factors associated with ROP are difficult to alter in clinical practice. Specifically, the ability to restrict oxygen administration to prevent ROP must be balanced with the need to provide sufficient supplemental oxygen to prevent death. Accordingly, the most recent Cochrane review1 shows that compared with a higher oxygen saturation target range, a lower target range significantly decreased the incidence of surgical ROP (relative risk 0.72) at the same that …

View Full Text

Footnotes

  • Contributors SV designed the study and drafted the initial manuscript. GG is responsible for literature search and reviewed the scientific content of the manuscript.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; internally peer reviewed.

  • Data sharing statement This study has no additional unpublished data.